Update of survival and cost of metastatic melanoma with new drugs: Estimations from the MelBase cohortM. Kandel, Isabelle Borget, Thierry Lesimple et al.|European Journal of Cancer|2018Cited by 38
Quality‐of‐life assessment in French patients with metastatic melanoma in real lifeM. Kandel, Isabelle Borget, Brigitte Dréno et al.|Cancer|2019Cited by 14
Cost-Effectiveness Analysis of Sequential Treatment Strategies for Advanced Melanoma in Real Life in FranceM. Kandel, Isabelle Borget, Julie De Quatrebarbes et al.|Current Oncology|2022Cited by 5